
Tenet Healthcare Corp
THCNYSECIK 70318HealthcareFiscal year ends Dec 31
Reports and events: 401 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2021-05-1216:31 ET | 8-K | 5.07 Shareholder vote results | 0001193125-21-159125 |
| 2021-04-3016:17 ET | 10-Q | Quarterly reportPeriod 2021-03-31 | 0000070318-21-000017 |
| 2021-04-2316:31 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-21-129073 |
| 2021-04-2216:36 ET | SC 13D/A | Ownership report, active investor, amended | 0001140361-21-013908 |
| 2021-04-2016:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000070318-21-000012 |
| 2021-03-2617:04 ET | DEF 14A | Proxy statementPeriod 2021-05-06 | 0001193125-21-096716 |
| 2021-03-2517:41 ET | SC 13D/A | Ownership report, active investor, amended | 0001140361-21-009855 |
| 2021-03-0216:32 ET | 8-K/A | 5.02 Departure or appointment of officers or directors | 0001193125-21-065584 |
| 2021-02-1917:02 ET | 10-K | Annual reportPeriod 2020-12-31 | 0000070318-21-000008 |
| 2021-02-0916:18 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000070318-21-000004 |
| 2021-02-0417:15 ET | SC 13D/A | Ownership report, active investor, amended | 0001140361-21-003427 |
| 2021-01-2516:30 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-21-016277 |
| 2021-01-1117:16 ET | 8-K | 2.02 Results of operations | 0001193125-21-006379 |
| 2021-01-0816:30 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-21-005244 |
| 2020-12-2317:00 ET | 8-K | 8.01 Other events | 0001193125-20-326126 |
| 2020-12-2217:20 ET | SC 13D/A | Ownership report, active investor, amended | 0000905148-20-001303 |
| 2020-12-1017:21 ET | 8-K | 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-20-315019 |
| 2020-11-0610:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-20-287579 |
| 2020-10-3018:00 ET | 10-Q | Quarterly reportPeriod 2020-09-30 | 0000070318-20-000043 |
| 2020-10-2016:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000070318-20-000038 |
| 2020-09-1617:06 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-20-247267 |
| 2020-09-0117:08 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-20-237290 |
| 2020-08-0316:19 ET | 10-Q | Quarterly reportPeriod 2020-06-30 | 0000070318-20-000036 |
| 2020-08-0316:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000070318-20-000035 |
| 2020-06-1616:29 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-20-170420 |
| 2020-06-0217:06 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-20-158623 |
| 2020-05-2917:30 ET | 8-K | 5.07 Shareholder vote results | 0001193125-20-155965 |
| 2020-05-0416:20 ET | 10-Q | Quarterly reportPeriod 2020-03-31 | 0000070318-20-000028 |
| 2020-05-0416:17 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000070318-20-000027 |
| 2020-04-2708:15 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-20-120303 |
| 2020-04-1716:24 ET | DEF 14A | Proxy statementPeriod 2020-05-28 | 0001193125-20-110683 |
| 2020-04-0716:40 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-20-100508 |
| 2020-04-0319:12 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000070318-20-000019 |
| 2020-04-0207:53 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000070318-20-000016 |
| 2020-03-2417:04 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-20-083944 |
| 2020-02-2817:22 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-20-057054 |
| 2020-02-2416:28 ET | 10-K | Annual reportPeriod 2019-12-31 | 0000070318-20-000014 |
| 2020-02-2416:24 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000070318-20-000013 |
| 2020-01-1408:01 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure | 0000070318-20-000003 |
| 2019-12-1310:02 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000070318-19-000060 |
| 2019-11-1216:34 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000070318-19-000058 |
| 2019-11-0416:28 ET | 10-Q | Quarterly reportPeriod 2019-09-30 | 0000070318-19-000056 |
| 2019-11-0416:17 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000070318-19-000054 |
| 2019-09-1316:16 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-19-244876 |
| 2019-08-2617:29 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-19-229556 |
| 2019-08-2019:10 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000070318-19-000047 |
| 2019-08-1516:45 ET | SC 13D/A | Ownership report, active investor, amended | 0000905148-19-000803 |
| 2019-08-1320:47 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-19-219265 |
| 2019-08-1207:44 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-19-218495 |
| 2019-08-0917:16 ET | 8-K/A | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000070318-19-000045 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 15, 2026, 02:42 ET. Listed shows no prices and gives no investment advice.